Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel C7-position stereospecific method enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally using cost effective ruthenium catalysis.
Efficient ruthenium-catalyzed method reduces costs and environmental load for high-purity pharmaceutical intermediates manufacturing supply chain.
Patent CN113024518A details a streamlined 3-step halogenation route for Erdafitinib, offering high purity and reduced costs for pharmaceutical manufacturers.
Novel preparation method avoids acyl chloride instability. Achieves >99.5% purity. Cost-effective API intermediate manufacturing solution for global supply chains.
Patent CN117510377A details a novel 4-step synthesis for high-purity Fmoc-Glu-OtBu. This method ensures cost reduction and supply chain reliability for peptide manufacturing.
Patent CN101475519B details a scalable route for NHE1 inhibitor intermediates, offering improved yields and supply chain reliability for cardiovascular drug manufacturing.
Patent CN116514819A reveals a metal-free synthesis for 1,2,3-triazoloquinoxaline. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN102964287B reveals a green Fischer indole route for 3-(4-chlorobutyl)-5-cyanoindole, offering safer API manufacturing and reduced supply chain risks.
Novel synthesis of oxindole spliced derivatives via MBH carbonates offering high purity and scalable antitumor intermediate production for global supply chains.
Patent CN121342656A reveals copper-catalyzed BCN-OSu synthesis improving yield and purity. Enables cost reduction and reliable supply chain for bio-orthogonal reagents.
Patent CN103435635B reveals improved TMPMgClLiCl synthesis. Enhances yield and supply chain stability for pharmaceutical intermediate manufacturing globally.
Novel mild route for APJ agonist intermediate. Optimized bromination and Pd-catalyzed carbonylation ensure stable supply and cost efficiency.
Patent CN107235902A details a mild synthesis route for antitumor licochalcone A derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel two-step copper-catalyzed route for azabicyclo hexanone. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing.
Novel synthesis route for chiral nitrophenol intermediates reduces cost and improves purity. Reliable supply for pharmaceutical manufacturing scale-up.
Patent CN108794448B reveals a high-yield Pd-catalyzed route for Trelagliptin, offering superior purity and cost efficiency for API manufacturing supply chains.
Advanced preparation method for (R)-1-Boc-3-aminopiperidine via chiral resolution. Safe, scalable process for DPP-IV inhibitor intermediates with reduced costs.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Patent CN114232013B reveals a metal-free electrochemical route for indoloquinolines. Discover cost-effective, green manufacturing solutions for high-purity pharmaceutical intermediates.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.